Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Las Vegas Sands heads into its October 21 earnings report with Goldman Sachs cutting its price target again, short sellers adding quietly to positions, and the stock still sitting more than 50% below where most analysts think it should trade.
The most significant development since the last note is Goldman's move on Tuesday. Analyst Lizzie Dove lowered her target from $55 to $47, maintaining a Buy rating, but the cut is notable: this is Goldman's second target reduction in three months on LVS, and the new target still sits 27% above the current price of $37.04. That gap illustrates the Street's collective dilemma. The consensus direction of travel has been unambiguously lower on targets. Barclays trimmed from $59 to $57 on October 9. Macquarie cut to $56 from $62 on October 7. The bulls are holding their ratings but trimming their ambitions on each pass, while the stock has clawed back about 2% on the week after falling 13.5% over the prior month. Wolfe Research initiated at Peer Perform in September without a target, and Argus Research's downgrade to Hold in late July remains the starkest expression of diminishing conviction. The mean target across the Street stands near $57.86, a figure that now looks stretched given where Goldman, the most aggressive bull, has landed.
Positioning in the lending market is remarkably relaxed for a stock with this much headline risk. Short interest has climbed 5.5% on the week and 17% over the past month, reaching about 2.7% of the free float, a low absolute level despite the directional move. Borrow remains almost entirely uncontested. Availability is extremely loose, with shares available to borrow running at more than 35 times the current short position, and cost to borrow has drifted lower to 0.38%, down roughly 5% on the week. The ORTEX short score of 41.6 sits in the 42nd percentile, unremarkable by any standard. This is not a stock where short sellers are pressing an aggressive directional bet. The gradual build in short interest looks more like hedging activity than a crowded short thesis.
Options traders are equally measured. The put/call ratio at 0.46 is only marginally above its 20-day average of 0.45, and the z-score of 0.45 is well within normal range. The 52-week high on the PCR is 0.93, so the current reading is closer to the bullish extreme of the past year than the defensive one. Call flow still dominates, which sits oddly alongside the target cuts but is consistent with a market that views the stock's decline as an opportunity rather than a signal of deeper trouble.
The ownership structure adds an important layer to this picture. Miriam Adelson holds a 13D activist stake on the SEC register, disclosed at 52.7% of class as of an August 11 filing, up from 51.5% previously. As with all 13D/G positions, this is as-last-disclosed around the 5% threshold event, and her actual holding may have moved since without a further filing requirement. Still, with that concentration at the family level, the effective free float available for institutional action is narrow, which partly explains why short interest remains modest even as the stock has de-rated sharply. State Street added 919,000 shares through September, and T. Rowe Price added 844,000, suggesting some active managers are treating the pullback as a buying opportunity at the institutional level.
The last reported earnings print, in July, produced a modest 1.2% one-day move followed by a 6.8% gain over five days. That reaction pattern suggests the company has, at least recently, been able to deliver results that support the bull case on a short horizon. Whether the October 21 print lands in that territory depends on Macau volumes and Singapore performance in the quarter, neither of which is visible from this data. What is clear is that Goldman has moved its goalposts twice in three months, the stock is still trading at roughly 6.7x EV/EBITDA against a historical range of 12x to 14x, and the gap between where analysts think LVS should be and where it actually is has not narrowed despite the partial recovery this week.
The October 21 print becomes the single most important data point: how much of the Street's continued optimism on Macau and Singapore is validated, and whether a third round of target cuts follows or the trend finally reverses.
See the live data behind this article on ORTEX.
Open LVS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
